<< BACK TO NEWS SECTION

Plattsburgh, NY—Monaghan Medical Corporation, the maker of the AeroChamber® Valved Holding Chamber, (“VHC”) recently announced its newest product, the Asthma Management Program featuring Doc Monaghan™. The program consists of a lively video or DVD, featuring a young boy who just learned he has asthma and an engaging animated character named “Doc Monaghan™.” The program also contains a comprehensive educational packet including a child’s storybook, a parent handbook and a coloring book. Slated to hit hospitals by November 1st, 2006, the program handles topics ranging from asthma medications, peak flows and ‘staying in the zones,’ as well as understanding and avoiding asthma triggers. The Doc Monaghan™ character conveys the importance of managing asthma on a daily basis in easy to understand language for both children and parents alike. The program was developed by a team of certified asthma educators dedicated to improving the life of children with asthma as well as their caregivers. The overall objective of the program is to meet the growing need for asthma education for prevention and management. To date, asthma is reported to be the third-ranking cause of hospitalization among those younger than 15 years of age. The Doc Monaghan™ program hopes to aid in the prevention of hospitalization through education. All items in the program are available in English and Spanish. Monaghan Medical Corporation is a global leader in the manufacture and sale of aerosol drug delivery devices, asthma management products and a supplier to major pharmaceutical companies involved with respiratory medicine worldwide.

AirLogix Again Earns Full NCQA Disease Management Certification

DALLAS, TX (December 14, 2005) -- AirLogix, an experienced and trusted leader in chronic respiratory disease management, today announced that it has again received full accreditation from NCQA (National Committee for Quality Assurance) for its disease management programs in asthma and COPD. The accreditation includes both NCQA Practitioner - and Patient - oriented processes.

NCQA, the nation's leader in healthcare performance measurement and oversight, currently accredits more than half of the nation's HMOs. NCQA also has broad support among employers with nearly 75% of the nation's largest employers using NCQA accreditation and HEDIS® data to guide choices among health plans.

Susan B. Riley, CEO of AirLogix, stated, "The staff of AirLogix strives for excellence on a daily basis. We take great pride in working to improve the health of our members and the trusting relationships we establish with our customers. Earning full NCQA disease management accreditation demonstrates this excellence, and we are deeply honored to receive it once again. We recognize that health plans demand a high level of excellence and NCQA accreditation demonstrates that we meet, and very often exceed the health plans’ expectations for chronic respiratory disease management.”

About NCQA

NCQA is a private, non-profit organization dedicated to improving healthcare quality. For more information, please visit www.ncqa.org. NCQA accredits and certifies a wide range of health care organizations, recognizes physicians and physician groups in key clinical areas, and manages the evolution of HEDIS® - a registered trademark of NCQA and the tool the nation’s health plans use to measure and report on their performance. NCQA is committed to providing health care quality information through the Internet, media and data licensing agreements in order to help consumers, employers and others make more informed health care choices.

About AirLogix

AirLogix is an experienced and trusted leader in chronic respiratory disease management. Through compassion and dedication, the AirLogix team has delivered effective, patient-centric asthma and COPD programs to over 500,000 members. Specializing in chronic respiratory disease, AirLogix uses self-care therapies, in-home interaction and powerful informatics processes to deliver highly effective clinical results, enhanced patient-provider satisfaction and greater cost reductions in respiratory management. For more information, please visit www.AirLogix.com.

Contact: Kate Leach 214.576.2065

<< BACK TO NEWS SECTION